Giuliani J, Mangiola D, Napoli G, Muraro S, et al. Cost-effectiveness of liposomal irinotecan (nal-IRI) combined with 5-fluorouracil and leucovorin in second or subsequent lines for metastatic pancreatic cancer in Italy. It can be done. Pancreatology 2025 Aug 12:S1424-3903(25)00581-2. doi: 10.1016/j.pan.2025.
PMID: 40829957